Status:
COMPLETED
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
Lead Sponsor:
Command Hospital, India
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
12-30 years
Phase:
PHASE4
Brief Summary
To study the effects of GLP 1 analogues and DPP 4 inhibitors on newly detected type 1 diabetes patients.
Detailed Description
Inclusion criteria T1DM \<3 months GAD Antibody+ Stimulated C peptide\<0.5ng/ml Ketosis at onset Age \< 30 yr Exclusion criteria Age \> 30 yr Pancreatic disease significant systemic complication
Eligibility Criteria
Inclusion
- T1DM \<3 months
- GAD Antibody+ or Stimulated C peptide\<0.5 ng/ml
- Ketosis at onset
- Age \< 30 yr
Exclusion
- Age \> 30 yr
- Pancreas disease
- Significant systemic disease
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01235819
Start Date
November 1 2010
End Date
September 1 2011
Last Update
July 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Command Hospital
Lucknow, Uttar Pradesh, India, 226002